Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP260082.RAaW6A_clVc1NP8I15f1jNGAqghgMeOycXmmmvMaGShTk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP260082.RAaW6A_clVc1NP8I15f1jNGAqghgMeOycXmmmvMaGShTk130_assertion type Assertion NP260082.RAaW6A_clVc1NP8I15f1jNGAqghgMeOycXmmmvMaGShTk130_head.
- NP260082.RAaW6A_clVc1NP8I15f1jNGAqghgMeOycXmmmvMaGShTk130_assertion description "[However, DST suppressor patients belonged more frequently to the BCL1 carriers group (41 out of 69 patients, 59.4% vs 9 out of 26 patients, 34.6%, p=0.0039), had smaller total adenoma size (2.4�0.2 cm vs 3.5�0.4 cm, p=0.04), and lower incidence of bilateral adrenal masses (18.8% vs 46.2%, p=0.01).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP260082.RAaW6A_clVc1NP8I15f1jNGAqghgMeOycXmmmvMaGShTk130_provenance.
- NP260082.RAaW6A_clVc1NP8I15f1jNGAqghgMeOycXmmmvMaGShTk130_assertion evidence source_evidence_literature NP260082.RAaW6A_clVc1NP8I15f1jNGAqghgMeOycXmmmvMaGShTk130_provenance.
- NP260082.RAaW6A_clVc1NP8I15f1jNGAqghgMeOycXmmmvMaGShTk130_assertion SIO_000772 21738001 NP260082.RAaW6A_clVc1NP8I15f1jNGAqghgMeOycXmmmvMaGShTk130_provenance.
- NP260082.RAaW6A_clVc1NP8I15f1jNGAqghgMeOycXmmmvMaGShTk130_assertion wasDerivedFrom befree-20150227 NP260082.RAaW6A_clVc1NP8I15f1jNGAqghgMeOycXmmmvMaGShTk130_provenance.
- NP260082.RAaW6A_clVc1NP8I15f1jNGAqghgMeOycXmmmvMaGShTk130_assertion wasGeneratedBy ECO_0000203 NP260082.RAaW6A_clVc1NP8I15f1jNGAqghgMeOycXmmmvMaGShTk130_provenance.